Form 6-K Super Group (SGHC) Ltd For: Dec 05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
December 2022
Commission File Number: 001-41253
Super Group (SGHC) Limited
(Translation of registrants name into English)
Super Group (SGHC) Limited
Bordeaux Court, Les Echelons
St. Peter Port, Guernsey, GY1 1AR
Telephone: +44 (0) 14 8182-2939
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On December 5, 2022, Super Group (SGHC) Limited (the Company) issued a press release reminding (i) the holders of its outstanding public warrants to purchase ordinary shares of the Company, no par value (the Ordinary Shares), which warrants trade on the New York Stock Exchange (NYSE) under the symbol SGHC WS (the public warrants) to tender their warrants in the Companys ongoing exchange offer and (ii) all holders of public warrants or private placement warrants to purchase Ordinary Shares (the private placement warrants) to provide their consent to an amendment to the warrant agreement by 12:01 A.M. Eastern time on December 12, 2022. A copy of such press release is attached hereto as Exhibit 99.1.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SUPER GROUP (SGHC) LIMITED | ||||||
Date: December 5, 2022 | By: | /s/ Robert James Dutnall | ||||
Name: | Robert James Dutnall | |||||
Title: | Authorized Signatory |
EXHIBIT INDEX
Exhibit No. |
Description | |
99.1 | Press Release, dated December 5, 2022 |
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
- FendX Announces Corporate Update
- Vaxxinity Issues Shareholder Letter
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!